The Collaborative Edge: Pfizer's Innovation Secret? Pfizer's success in the biopharmaceutical industry hinges on its internal capabilities and a strategic embrace of external collaboration. This proactive approach, spanning diverse technological frontiers, fuels innovation across its operations. From partnering with QuantumBasel and D-Wave to optimiz
Key facts today
Jefferies has revised Pfizer's price target to $32 from $34 while keeping a 'Buy' rating on the stock.
William Blair analysts see Viking Therapeutics' VK2735 as a chance for Pfizer (PFE) to re-enter the obesity market, competing with Novo Nordisk and Eli Lilly.
16,805.26
0.00 BRL
43.24 B BRL
343.01 B BRL
About Pfizer
Sector
Industry
CEO
Albert Bourla
Website
Headquarters
New York
Founded
1849
ISIN
BRPFIZBDR006
FIGI
BBG0017227L4
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
PFEAt the current price, I'm looking for a retest toward the daily target zone located on the chart. On 3/21 PFE announced news about dropping the decision to move forward with the weight loss drug. Since then, price dropped down in spike like fashion. After the big volume spike, on that date, volume c
OptionsMastery: Looking like more downside on PFE!🔉Sound on!🔉
📣Make sure to watch fullscreen!📣
Thank you as always for watching my videos. I hope that you learned something very educational! Please feel free to like, share, and comment on this post. Remember only risk what you are willing to lose. Trading is very risky but it can change your life!
12/23/24 - PFE: new BUY mechanical signal.12/23/24 - PFE: new BUY signal chosen by a rules based, mechanical trading system.
PFE - BUY
Stop Loss @ 24.80
Entry BUY @ 26.71
Target Profit @ 29.54
Analysis:
1. On the Higher timeframe - Prices have stayed above the lower channel line of the ATR (Average True Range) Channel
2. Higher timefram
Pfizer Wave Analysis – 27 March 2025
- Pfizer broke support level 25.20
- Likely to fall to support level 24.70
Pfizer recently broke the pivotal support level 25.20 (lower border of the sideways price range inside which the price has been moving from November).
The breakout of the support level 25.20 accelerated the active
Pfizer: Oh Buyer Where Art Thou?Pfizer has struggled for years, and some traders may see risk of further downside.
The first pattern on today’s chart is the slide to a new 12-year low in October and November. The drugmaker barely retraced half that move at subsequent highs. It also remained mostly below its October low of $26.87.
FEAR PRESENTS A BUYING OPPORTUNITYThe deteriorating sentiment over the last 3 years has created a substantial buying opportunity.
The negative sentiment can be attributed to 4 main things- decreased EPS/ Net Income since 2022/2023 (end of COVID $$), increased debt levels post-Seagen acquisition and revenue challenges due to upcomi
PFE Operation PlanFor this trade on Pfizer (PFE), we will implement a staggered entry strategy with three designated entry points at $26, $25, and $24.5. This approach allows for a cost-averaging method and improved risk management as the market fluctuates.
Our profit targets are set at $28, $30.5, and $31, ensuring
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063Yield to maturity
6.31%
Maturity date
May 19, 2063
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053Yield to maturity
6.13%
Maturity date
May 19, 2053
See all PFIZ34 bonds
Curated watchlists where PFIZ34 is featured.